King County’s comics have also become a method to more effectively communicate health information to people who speak English ...

In Philadelphia, the leading causes of death are heart disease, cancer and unintentional drug overdose. While some of these deaths are caused by things out of our control – like genetics – many are ...

Dr. Sayone Thehalolipavan, San Diego County’s new public health officer, poses for a photo at the Public Health Services building on Thursday, May 22, 2025 in San Diego, CA.

As a public health official, Jay K. Varma has handled putative anthrax attacks. He says an AI-simulated bioterror attack could cause real-world chaos.

The National Cancer Policy Forum held a poster session in concert with the workshop on Cancer Engineering: The Convergence of Engineering and Health to Advance Cancer Research and Care. This workshop ...

At noon on Tuesday, May 6, educators from the Rape & Crisis Abuse Center of Fargo-Moorhead are giving a free presentation at the library in observance of Mental Health Awareness Month.

ClearB Therapeutics, Inc., a company developing therapeutic vaccines designed to drive a functional cure for Hepatitis B, announced today that an abstract wi ...

--BioAtla, Inc., a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic antibody therapeutics for the treatment of solid tumors, today announced ...

The poster can be accessed through the “Supporting Publications” tab on the “Our Approach” section of the Zentalis website on the day of the presentation.

Democratic attorneys general and governors in 23 states and Washington, DC, have filed a lawsuit against the US Department of Health and Human Services and HHS Secretary Robert F. Kennedy Jr ...

Presentations will feature potential best-in-class pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 Erasca will also present potential first-in-class examples of direct SMP complex ...

SAN DIEGO, March 20, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody ...